Expertise in
2
conditions

Nesrin Karabul

Frankfurt Am Main, HE, DE 
Expertise in
2
conditions
Frankfurt Am Main, HE, DE 

Overview

Nesrin Karabul practices practicing medicine in Frankfurt Am Main, Germany.

Karabul is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Pompe Disease, Fabry Disease, and Beukes Familial Hip Dysplasia.

They are actively involved in clinical research, co-authoring 26 peer reviewed articles and participating in 2 clinical trials.

Locations

Frankfurt Am Main, HE, Germany
Other Locations
Bochum, NW, Germany
Mainz, RP, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-Label, Fixed-Sequence, Ascending-Dose, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Intravenous Infusions of ATB200 Co-Administered With Oral AT2221 in Adult Subjects With Pompe Disease
An Open-Label, Fixed-Sequence, Ascending-Dose, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Intravenous Infusions of ATB200 Co-Administered With Oral AT2221 in Adult Subjects With Pompe Disease
Enrollment Status: Completed
Publish Date: October 23, 2025
Intervention Type: Drug
Study Drugs: ATB200, AT2221
Study Phase: Phase 1/Phase 2
A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
Enrollment Status: Completed
Publish Date: March 05, 2024
Intervention Type: Drug
View 1 Less Clinical Trial

26 Total Publications

Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS).
Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS).
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: December 02, 2020

Frequently Asked Questions about Nesrin Karabul

Is Nesrin Karabul a top-rated expert for Pompe Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Nesrin Karabul is classified as an Advanced expert for Pompe Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Nesrin Karabul participate in research or clinical trials?

Yes. Nesrin Karabul has published 26 articles and abstracts on conditions like Pompe Disease. You can view a list of Nesrin Karabul's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Karabul's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile